Premium
Early markers for protective mechanisms during rush venom immunotherapy
Author(s) -
Bussmann C.,
Xia J.,
Allam J.P.,
Maintz L.,
Bieber T.,
Novak N.
Publication year - 2010
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/j.1398-9995.2010.02430.x
Subject(s) - immunology , venom , allergy , medicine , peripheral blood mononuclear cell , immunotherapy , intracellular , monocyte , immune system , biology , biochemistry , in vitro
To cite this article: Bussmann C, Xia J, Allam J‐P, Maintz L, Bieber T, Novak N. Early markers for protective mechanisms during rush venom immunotherapy. Allergy 2010; 65 : 1558–1565. Abstract Background: Allergen‐specific venom immunotherapy (VIT) represents the only rational‐based option to treat allergic sensitizations against bee and wasp venom. So far, there is not much knowledge about early induction of protective and tolerogenic pathways during VIT. Objectives: To identify the earliest markers for protective mechanisms against allergic reactions in the peripheral blood during the build‐up phase of VIT. Methods: PBMC and monocytes were isolated, and serum samples were taken before and during a five day build‐up phase from 65 hymenoptera venom allergic patients. Expression level of tolerogenic markers was analyzed on mRNA and protein level. Serum levels of different soluble tolerogenic factors were measured. Results: We observed significantly enhanced tryptophan degradation, elevated ILT4 expression of monocytes as well as IL‐10 production of CD3 + T cells only a few hours after the first injection on day 1, followed by increased IL‐10 serum levels, monocyte apoptosis and elevated intracellular cAMP levels of monocytes on day 3 combined with a higher ILT3 protein expression and IL‐10 secretion of monocytes on day 5. Conclusion: From these data, we conclude that tryptophan depletion, ILT3/4‐mediated inhibition, higher IL‐10 production as well as intracellular cAMP might contribute to early induction of protective mechanisms against allergic reactions during the build‐up phase of VIT.